Earnings: ECI Q3 net profit held back by Laurel acquisition

Third-quarter net profit rose 3% despite a 26% jump in revenue as losses from Laurel Networks made a big dent in the bottom line.

By YIGAL GRAYEFF
November 4, 2005 00:54
3 minute read.

 
X

Dear Reader,
As you can imagine, more people are reading The Jerusalem Post than ever before. Nevertheless, traditional business models are no longer sustainable and high-quality publications, like ours, are being forced to look for new ways to keep going. Unlike many other news organizations, we have not put up a paywall. We want to keep our journalism open and accessible and be able to keep providing you with news and analyses from the frontlines of Israel, the Middle East and the Jewish World.

As one of our loyal readers, we ask you to be our partner.

For $5 a month you will receive access to the following:

  • A user experience almost completely free of ads
  • Access to our Premium Section
  • Content from the award-winning Jerusalem Report and our monthly magazine to learn Hebrew - Ivrit
  • A brand new ePaper featuring the daily newspaper as it appears in print in Israel

Help us grow and continue telling Israel’s story to the world.

Thank you,

Ronit Hasin-Hochman, CEO, Jerusalem Post Group
Yaakov Katz, Editor-in-Chief

UPGRADE YOUR JPOST EXPERIENCE FOR 5$ PER MONTH Show me later Don't show it again

ECI Telecom's third-quarter net profit rose 3% despite a 26% jump in revenue as losses from Laurel Networks, which the company bought in June for $88m., made a big dent in the bottom line. The Petah Tikvah-based broadband telecommunications equipment maker said on Thursday that in the three months ended September 30, net profit edged up to $6.2 million from $6m. in the same period a year earlier. Earnings per diluted share were unchanged at five cents while revenue rose to $162m. from $128m. Analyst expectations for EPS ranged from 5 to 6 cents and for revenue of $156.4m. to $159.5m., as compiled by Thomson Financial Network. The results included those of Laurel Networks, which had revenue of $2m. and losses of $7.7m. Excluding the effect of Laurel, ECI's net income increased to $13.9m. The company said it expects quarter-on-quarter growth in profits and revenue in the fourth quarter and that 2006 growth would exceed that of the telecommunications equipment sector. However, it didn't provide more details. In its previous earnings report, the company had said the acquisition of Laurel would dilute its results until the second half of next year. For the first nine months of the year, net profit rose to $32.2m. from $1.3m., diluted EPS rose to 27 cents from one cent, and revenue rose to $461m. from $357m. Shares rose 3.3% to $7.81 in morning trading on Nasdaq. M-Systems Q3 net profit soars 128% M-Systems reported record third-quarter earnings as strong demand in all its markets helped net profit soar 128% and revenue 55%. The Kfar Saba-based company, which develops flash-data storage for digital consumer electronics products, said on Thursday that net profit in the three months ended September 30 surged to $13.9m. from $6.1m. in the same period a year earlier. Diluted earnings per share rose to 34 cents from 16 cents and revenue rose to $132.6m. from $85.7m. Analyst expectations for EPS ranged from 24 to 30 cents and for revenue they ranged from $109.9m. to $128m., as compiled by Thomson Financial Network. The company raised its 2005 EPS forecast to $1.08 from prior guidance of $1 and its revenue outlook to $490m. from $450m., with president and chief executive Dov Moran saying that the upgrade reflects strong demand. Despite the strong report, shares were unchanged at $32.87 during morning trading on Nasdaq. Syneron Q2 net profit doubles; new CEO appointed Medical devices company Syneron said on Thursday that third-quarter net profit doubled and that it has appointed a new chief executive. In the three months ended September 30, net income jumped to $14.6m. from $7.3m. in the same period a year earlier, earnings per diluted share increased to 53 cents from 29 cents, and revenue increased to $25m. from $14.9m. Analyst expectations for EPS ranged from 34 to 38 cents and for revenue they ranged from $20.76m. to $23.88m., as compiled by Thomson Financial Network. The company said revenue was boosted by sales of its VelaSmooth device in North America and it raised its 2005 revenue guidance to a range of $91m. to $92m. from $84m. to $85m. The VelaSmooth, which received approval from the US Food and Drug Administration in July, is used to temporarily reduce the appearance of cellulite and to relieve minor muscle aches. Nine-month net profit rose to $29m. from $19.1m. and revenue rose to $63.7m. from $40.4m. Separately, Syneron appointed chief financial officer David Schlachet as its CEO, replacing Moshe Mizrahy, who has been with the company since its inception and oversaw its listing on Nasdaq in 2004. Syneron also appointed Shimon Eckhouse as active chairman. Shares climbed 3.2% to $39.78 in early trading on Nasdaq.

Related Content

The Teva Pharmaceutical Industries
April 30, 2015
Teva doubles down on Mylan, despite rejection

By GLOBES, NIV ELIS